Abbreviations: BAP1, BRCA1-associated protein-1; Cas9, CRISPR-associated protein 9; CDK2, cyclin-dependent kinase 2; CDKN2A, cyclin-dependent kinase inhibitor 2A; CRISPR, clustered regularly interspaced short palindromic repeats; FGFR2, fibroblast growth factor receptor 2; MPM, malignant pleural mesothelioma; NF2, neurofibromatosis type 2; qRT-PCR, quantitative real-time PCR; Rb, retinoblastoma; sgRNA, single guide RNA; sh, short hairpin; YAP, yes-associated protein. 
| INTRODUC TI ON
Malignant pleural mesothelioma, an aggressive neoplasm that arises from pleural mesothelial cells, is associated with asbestos exposure after 20-40 years of latency. 1, 2 Patients with MPM are usually diagnosed at an advanced stage of the disease, and their prognosis remains poor. Median survival after diagnosis is 6-12 months, and the standard-of-care agents, pemetrexed and cisplatin, are relatively ineffective at increasing the survival time. 3, 4 Asbestos could have multiple effects in carcinogenesis, but the molecular mechanisms underlying asbestos-induced tumorigenesis are still unclear. 5, 6 Recent molecular biological studies have revealed frequent genetic alterations in patients with MPM, with 3 key tumor suppressor genes, NF2, CDKN2A, and BAP1, being identified at rates of 30%-50%, 70%, and 20%-60% in MPM cases, respectively. [7] [8] [9] [10] [11] [12] [13] Moreover, the status of these 3 genes has significant prognostic implications. Homozygous CDKN2A deletions are a poor prognostic indicator for patients with MPM. [14] [15] [16] Deletion of NF2 is associated with increased cell proliferation, invasiveness, spreading, and migration. 17, 18 However, the molecular mechanism by which normal mesothelial cells acquire a carcinogenic phenotype in humans is not well understood. In this study, we first examined the effect of NF2 loss on the gene expression profile in human normal mesothelium cell line MeT-5A and then characterized the cellular phenotype in vitro.
We focused on one of the NF2-related genes, FGFR2, and showed the involvement of FGFR2 in the cellular phenotype in NF2-KO cell clones. We also investigated the association between NF2 loss and FGFR2 expression in MPM tissues. Research Institute (Nagoya, Japan). HOMC-A4 and HOMC-D4 cell lines were maintained as described elsewhere. 19 MeT-5A and NCI-H2052 cell lines were maintained in RPMI-1640 (Wako, Osaka, Japan) medium containing 10% FBS (Sigma-Aldrich St. Louis, MO, USA) and penicillin-streptomycin (Wako) at 37°C in a 5% CO 2 air atmosphere.
| MATERIAL S AND ME THODS

| Cell culture
Three
| Gene knockout using the CRISPR/Cas9 system
The CRISPR/Cas9 system was used to disrupt the expression of the NF2 and FGFR2 genes, as described elsewhere. 20 pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang (plasmid #48138; Addgene, Watertown, MA, USA ). 20 In brief, an sgRNA sequence was selected using an Optimized CRISPR Design (http://crispr.mit.edu/). The sgRNA sequence for NF2 was 5′-AAACATCTCGTACAGTGACA-3′
and that for FGFR2 was 5′-GTACCGTAACCATGGTCAGC-3′, corresponding to exons 8 and 1, respectively. The plasmid expressing hCas9 and the sgRNA was prepared by ligating oligonucleotides into the BbsI site of PX458 (NF2/PX458 and FGFR2/PX458). To establish a knockout clone, 1 μg NF2/PX458 or FGFR2/PX458 plasmid was nucleofected into cells (1 × 10 6 cells) using a 4D-Nucleofector instrument (Lonza Japan, Tokyo, Japan). After 3 days, the cells expressing GFP were sorted using FACS (BD Biosciences, San Jose, CA, USA). A single clone was selected, expanded, and then used for biological assays. For sequence analysis of the NF2 gene, the following primer set was used: forward, 5′-CAGTTTTGCTTCTACCTGCC-3′ and reverse, 5′-GCCAGTTGAGCTTCCCAGTT-3′.
| Construction of RNAi vectors and expression vectors
To construct an RNAi vector, sh oligonucleotide was inserted into pLentiLox3.7 plasmid (Addgene) under the control of the U6 promoter. Two sh oligonucleotides were designed for the target sequence of the hairpin loop of YAP (sh1, 5′-TTCTATGTTCATTCCATCTCC-3′;
sh2, 5′-GAGTTCTGACATCCTTAAT-3′). A control shRNA vector was also constructed using a scrambled sequence for YAP (scr1, 5′-GGATAAACTAAGGGATAGGAA-3′). To construct the expression vector, cDNA fragments of WT YAP and NF2 were amplified by PCR using Prime STAR Max DNA polymerase (Takara Bio, Otsu, Japan). The phosphorylation-defective mutant YAP (YAP S127/381A
) was constructed by in vitro mutagenesis at codons 127 and 381 from serine to alanine (S127/381A). The cDNA fragments were then introduced into the pcDNA3.1 expression vector (Addgene). Backbone pcDNA3.1 was used as a control vector. The cells (1 × 10 6 cells) were nucleofected with 1 μg of each vector using a 4D-Nucleofector instrument (Lonza Japan).
| Quantitative real-time PCR
Quantitative real-time PCR analysis was carried out using SYBR Green I, as previously described. 21 GAPDH was used as an internal control. The primers used in this study are described in Table S1 .
| Complementary DNA microarray analysis
The experimental procedure for the cDNA microarray analysis was based on the manufacturer's protocol (Agilent Technologies, Santa Clara, CA, USA). In brief, cDNA synthesis and cRNA labeling with the cyanine 3 dye were carried out using the Agilent Low Input Quick Amp Labeling Kit (Agilent Technologies). The cyanine 3-labeled cRNA was purified, fragmented, and hybridized on a Human Gene Expression 4 × 44K v2 Microarray Chip containing 27 958 Entrez
Gene RNAs, using a Gene Expression Hybridization kit (Agilent Technologies). The raw and normalized microarray data have been submitted to the GEO database at NCBI (accession no. GSE116000;
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116000).
Gene set enrichment analysis was carried out according to the instructions.
| Cell growth assay
The cell growth rate was determined by an MTT assay. Briefly, the cells (1 × 10 3 cells/well) were seeded into a 96-well plate and cultured for indicated times. Subsequently, 10 μL MTT solution (5 mg/mL; Sigma-Aldrich) was added to each well, and the cells were further incubated for 4 hours. Next, the cell lysis buffer was added to the wells to dissolve the colored formazan crystals produced by MTT. The absorbance at 595 nm was measured using a SpectraMAX M5 spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).
| Soft agar colony formation assay
The soft agar colony formation assay was carried out as described previously. 22 The number of colonies was counted using Colony
Counter software (Keyence, Tokyo, Japan). The data are presented as mean ± SEM (n = 3).
| Wound healing assay and migration assay
The cells were cultured as a monolayer in 12-well plates. Upon reaching approximately 60%-70% confluence, wounds were made by scratching using pipette tips. After washing with PBS, the wounds were photographed every 24 hours. Ten thousand cells suspended in 100 μL serum-free medium were added into the upper chambers of a Transwell (8 μm for 24-well plate; Millipore, Tokyo, Japan), and culture medium was added into the lower chambers. After 24 hours, the cells were fixed by formalin and stained by 0.1% crystal violet. The number of colonies was manually counted under a microscope.
| Western blot analysis
Western blot analysis was carried out as described previously.
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The antibodies used in this study are described in Table S2 . Immune complexes were detected using ImmunoStar LD (Wako) in conjunction with a LAS-4000 image analyzer (GE Healthcare, Tokyo, Japan).
| Immunohistochemistry
Immunohistochemical analysis was carried out according to the procedure previously described. 23 The human mesothelioma tissue array was purchased from US Biomax (MS-801a; Rockville, MD, USA 
| Statistical analysis
Results are expressed as mean ± SE. Statistical significance between groups was determined using one-way ANOVA and Dunnett's com- (Table S3 ) and 77 genes whose expression was downregulated F I G U R E 4 Quantitative real-time PCR analysis. Eleven genes, whose upregulation (A) or downregulation (B) in neurofibromatosis type 2 knockout (NF2-KO) cell clones was detected in cDNA microarray analysis, were subjected to quantitative real-time PCR analysis using the SYBR Green method. Relative gene expression levels are shown after normalization to GAPDH mRNA expression. Mean values were compared with the normal control value to calculate relative amounts of transcripts. Data are presented as mean ± SEM (n = 3). *Statistically significant difference (P < .05) less than 0.2-fold (Table S4 ). In addition, with the aid of Gene Set Enrichment Analysis, the genes related to positive regulation of the cell cycle were shown to be significantly activated in the NF2-KO clones compared with the levels in the NF2-WT clones ( Figure S1A ).
The results of Gene Set Enrichment Analysis also showed that some of the downregulated genes overlapped with the genes whose expression levels were reported to be lower in patients with biphasictype MPM than in those with epithelial-type MPM ( Figure S1B ). , fibroblast growth factor receptor 2 (FGFR2), phosphorylation levels of MAPKs (P-ERK1/2, P-JNK, and P-p38), phospho-c-Jun (P-c-Jun), phospho-retinoblastoma (P-Rb), cyclin-dependent kinase 2 (CDK2), Cyclin D1, and phospho-yes-associated protein (P-YAP) in the parental MeT-5A cells, control NF2-WT clones, and NF2-KO clones. Cell lysates obtained were subjected to western blotting analysis to detect each protein level by using specific Abs. B, Effect of exogenous NF2 expression in NF2/NF2-KO clones on the protein levels of FGFR2, P-JNK, P-c-Jun, cyclin D1, CDK2, P-Rb, and P-YAP. The NF2/pcDNA3.1 vector was transfected in the NF2-KO clones using a 4D-Nucleofector instrument (Lonza Japan, Tokyo, Japan). C, Western blot analysis showing the protein expression of NF2 and FGFR2 in NF2-knockout human mesothelial cell lines HOMC-A4 and HOMC-D4. D, Western blot analysis showing the protein expression of NF2 and FGFR2 due to overexpression of NF2 in the mesothelioma cell line NCI-H2052. Cells were transfected with control pcDNA3.1 (Con-V) and WT NF2/ pcDNA3.1 vectors. After transfection, the cells were incubated for 48 hours, washed with PBS and lysed in loading buffer. The cell lysates obtained were subjected to western blotting analysis. GAPDH was used as an internal control (Figure 4) . The results of qRT-PCR further confirmed that rescuing NF2 had no significant effect on the mRNA expression of MGST2, COLEC12, NKD2, ACTA2, IFI27, or FAM155A genes ( Figure S2 ). These results strongly suggest that the affected gene products might function downstream of NF2 signaling.
| Effect of NF2 knockout on FGFR2 expression and cell cycle-related molecules
As therapy targeting the FGF-FGFR axis has emerged as a novel anticancer application in a panel of solid cancers, [27] [28] [29] we next focused on FGFR2, whose expression was found to increase in the NF2-KO MeT-5A cells ( Figure 5A ). In addition, the phosphorylation levels of both ERK and JNK MAPKs, increased in the NF2-KO clones, whereas the level of p38 MAPK remained constant ( Figure 5A ).
Similarly, the phosphorylation level of c-Jun increased in the NF2-KO cell clones ( Figure 5A ). Furthermore, both phosphorylation levels of a cell cycle regulator, Rb, and protein expression levels of CDK2
and cyclin D1 increased in the NF2-KO cell clones ( Figure 5A ). We also observed that, in spite of an abundant increase in the total YAP level, the YAP phosphorylation level decreased in the NF2-KO cell clones ( Figure 5A ). To confirm the effect of NF2 on the expression of these proteins, we utilized the exogenous NF2/NF2-KO cell clones.
Rescuing of NF2 protein expression resulted in a reduction in FGFR2 expression in the NF2/NF2-KO clones compared with that in the NF2-KO clones ( Figure 5B 
| Relationship between YAP activity and FGFR2 expression
It has been reported that NF2 mutation activates a downstream YAP oncogenic signaling pathway, which leads to cell cycle progression and induces carcinogenesis. 
| Immunohistochemistry for FGFR2 expression in patients with MPM
Finally, we undertook immunohistochemical analyses to examine the protein expression level of FGFR2 in 23 malignant mesotheliomas and 10 normal mesothelium tissue samples (Table 1 , Figure 8A ). Figure 8B ). Interestingly, the rate of positivity for FGFR2 signals in the NF2-negative MPM tissues (11 of 12 tissues, 91.7%) was significantly higher than that in the NF2-positive MPM tissues (2 of 11 tissues, 18.2%; Figure 8 ). Our analysis using data in the public domain (GSE2549 and GSE29354, deposited in GEO datasets) clarified that FGFR2 mRNA expression in patients with MPM was higher than that genes, some of which were reported to be downregulated in malignant mesothelioma.
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Fibroblast growth factor receptor family protein has been shown to be amplified and overexpressed in several cancer types. [32] [33] [34] [35] [36] [37] Expression of FGFR2 protein was observed in several types of cancer including breast and gastric cancer. 38, 39 Fibroblast growth factor receptor 1 has been reported to be a growth driver in MPM. 28, 40 Recent data reported by The Cancer Genome Atlas lung squamous cell carcinoma project showed that the FGFR tyrosine kinases are some of the most frequently altered kinase families in lung squamous cell carcinoma. 41 Interestingly, Quispel-Janssen et al 29 recently
reported that a subgroup of immortalized and primary MPM lines appeared to be highly sensitive to FGFR inhibition. They also showed an association between BAP1 loss and increased expression of the receptors FGFR1/3 and ligands FGF9/18. 
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